Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma
Abstract Oncogenic drivers of progression of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) such as c-MYC have downstream effects on intracellular metabolic pathways of clonal plasma cells (PCs). Thus, extracellular environments such as the bone marrow (BM) plasma...
Guardado en:
Autores principales: | Wilson I. Gonsalves, Katarzyna Broniowska, Erik Jessen, Xuan-Mai Petterson, Alexander Graham Bush, Jaimee Gransee, Martha Q. Lacy, Taro Hitosugi, Shaji K. Kumar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be1ea48f80f147afb852802099cac5d1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Coexistence of Prefibrotic Myelofibrosis with Monoclonal Gammopathy of Undetermined Significance: A Case Report
por: Omar M. Ismail, et al.
Publicado: (2021) -
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
por: Saemundur Rognvaldsson, et al.
Publicado: (2021) -
Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study
por: Nicola Hornung, et al.
Publicado: (2021) -
A nationwide study of patients with monoclonal gammopathy of undetermined significance with a 10-year follow-up in South Korea
por: Ka-Won Kang, et al.
Publicado: (2021) -
Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters
por: Pasiarski M, et al.
Publicado: (2019)